PT1435976E - Composição farmacêutica incluindo quito-oligómeros - Google Patents

Composição farmacêutica incluindo quito-oligómeros Download PDF

Info

Publication number
PT1435976E
PT1435976E PT02777769T PT02777769T PT1435976E PT 1435976 E PT1435976 E PT 1435976E PT 02777769 T PT02777769 T PT 02777769T PT 02777769 T PT02777769 T PT 02777769T PT 1435976 E PT1435976 E PT 1435976E
Authority
PT
Portugal
Prior art keywords
oligomers
chito
treatment
quito
chitin
Prior art date
Application number
PT02777769T
Other languages
English (en)
Portuguese (pt)
Inventor
Jon M Einarsson
Johannes Gislason
Peter Martin
Bahrke Sven
Original Assignee
Genis Ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genis Ehf filed Critical Genis Ehf
Publication of PT1435976E publication Critical patent/PT1435976E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Materials Engineering (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PT02777769T 2001-09-26 2002-09-26 Composição farmacêutica incluindo quito-oligómeros PT1435976E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum

Publications (1)

Publication Number Publication Date
PT1435976E true PT1435976E (pt) 2007-06-28

Family

ID=36700489

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02777769T PT1435976E (pt) 2001-09-26 2002-09-26 Composição farmacêutica incluindo quito-oligómeros

Country Status (13)

Country Link
US (2) US7985741B2 (enExample)
EP (1) EP1435976B1 (enExample)
JP (1) JP4613008B2 (enExample)
KR (1) KR20040062548A (enExample)
AT (1) ATE359797T1 (enExample)
CA (1) CA2507926C (enExample)
DE (1) DE60219653T2 (enExample)
DK (1) DK1435976T3 (enExample)
ES (1) ES2284935T3 (enExample)
IS (2) IS6085A (enExample)
PT (1) PT1435976E (enExample)
SI (1) SI1435976T1 (enExample)
WO (1) WO2003026677A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050070500A1 (en) * 2001-12-13 2005-03-31 Boucher L Isabelle Method of modulating release of saccharides and uses thereof
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
JP2007507516A (ja) * 2003-10-01 2007-03-29 オプティマー・ファーマスーティカルズ・インコーポレイテッド アミノ糖投与による哺乳動物の障害の治療及びアミノ糖の使用
US20070082851A1 (en) * 2003-11-24 2007-04-12 Optimer Pharmaceuticals Inc. Treatment of a condition in a mammal with administration of Compounds and Methods of Use
CA2551613A1 (en) * 2004-05-21 2005-12-01 Tottori University A composition comprising n-acetyl-d-glucosamine for treatment of wound
MX336736B (es) * 2005-06-14 2016-01-29 Genis Hf Composiciones de derivados de quitina parcialmente desacetilados.
US7485718B2 (en) 2005-06-16 2009-02-03 E. I. Du Pont De Nemours And Company Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
WO2007001282A2 (en) * 2005-06-16 2007-01-04 E.I. Dupont De Nemours And Company Low molecular weight polyglucosamines and polygalactosamines
KR100831335B1 (ko) * 2006-06-22 2008-05-22 부경대학교 산학협력단 인간 피부 섬유아세포에서 메트릭스메탈로프로테이나제-2의 발현 및 활성을 억제시키는키토올리고사카라이드 화합물 및 이를 함유한 메트릭스메탈로프로테이나제-2 억제제
EP2318014B1 (en) * 2008-07-18 2016-09-14 Genís hf. New composition for treating autoimmune disorders
KR20100060634A (ko) * 2008-11-28 2010-06-07 (주)아모레퍼시픽 미토콘드리아 활성화를 위한 조성물
KR101729137B1 (ko) * 2009-07-28 2017-04-26 (주)아모레퍼시픽 키토올리고당을 함유하는 피로회복용 조성물
US9186377B2 (en) 2011-06-03 2015-11-17 Maguire Abbey, Llc Method, composition, and articles for improving joint lubrication
EP3058826A1 (en) 2011-09-08 2016-08-24 Novozymes BioAG A/S Seed treatment methods and compositions
PL2748123T3 (pl) 2011-09-14 2024-05-13 Novozymes Bioag A/S Zastosowanie lipochito-oligosacharydów i/lub chito-oligosacharydów w kombinacji z mikroorganizmami solubilizującymi fosforany do poprawy wzrostu roślin
AU2012312006B2 (en) * 2011-09-23 2015-10-29 Novozymes Bioag A/S Chitooligosaccharides and methods for use in enhancing corn growth
CA2849898C (en) 2011-09-23 2020-10-27 Novozymes Bioag A/S Chitooligosaccharides and methods for use in enhancing plant growth
US9474828B2 (en) 2012-04-23 2016-10-25 Genis Hf. Self-hardening bioactive cement compositions with partially deacetylated chitin as bone graft substitutes
JP6285497B2 (ja) * 2016-06-07 2018-02-28 株式会社エバーライフ 鶏冠抽出物含有経口組成物及び鶏冠抽出物の香味に由来する摂取困難性の改善方法
KR101673368B1 (ko) 2016-07-14 2016-11-08 김기혁 공정가스 반응물의 콜드트랩 장치
EP4511042A4 (en) * 2022-04-21 2026-04-22 Therapeutikos Inc METHODS OF TREATING INFLAMMATION

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5919122B2 (ja) * 1976-10-12 1984-05-02 味の素株式会社 水溶性部分脱アセチル化キチン及びその製造法
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
JP2527317B2 (ja) * 1986-12-19 1996-08-21 ライオン株式会社 骨疾患治療剤
US6184037B1 (en) * 1996-05-17 2001-02-06 Genemedicine, Inc. Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
DE69733089T2 (de) * 1996-12-13 2005-09-29 Lescarden Inc. Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin
JP3062592B2 (ja) * 1997-05-30 2000-07-10 農林水産省食品総合研究所長 ２−アセチルアミノ−４−Ｏ−（２−アミノ−２−デオキシ−β−Ｄ −グルコピラノシル）−２−デオキシ−Ｄ −グルコースおよびその塩の製造法
US6492350B2 (en) * 2000-01-27 2002-12-10 Jdc (Hawaii) Inc. Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
EP1127574A1 (en) * 2000-02-22 2001-08-29 Food Industry Research and Development Institute Use of chitinous materials for inhibiting cellular nitric oxide production
CA2313836C (en) * 2000-03-15 2009-06-09 Cargill, Incorporated Chitosan and method of preparing chitosan
US20020119949A1 (en) 2001-02-26 2002-08-29 Asa Hellman Prophylactic teat treatment
MX336736B (es) * 2005-06-14 2016-01-29 Genis Hf Composiciones de derivados de quitina parcialmente desacetilados.

Also Published As

Publication number Publication date
EP1435976A1 (en) 2004-07-14
US8415326B2 (en) 2013-04-09
ES2284935T3 (es) 2007-11-16
US20110257381A1 (en) 2011-10-20
SI1435976T1 (sl) 2007-08-31
ATE359797T1 (de) 2007-05-15
DE60219653D1 (de) 2007-05-31
DE60219653T2 (de) 2008-01-03
JP4613008B2 (ja) 2011-01-12
WO2003026677A1 (en) 2003-04-03
IS7193A (is) 2004-03-22
CA2507926C (en) 2011-12-20
US20050004073A1 (en) 2005-01-06
DK1435976T3 (da) 2007-08-27
IS2783B (is) 2012-05-15
JP2005507891A (ja) 2005-03-24
US7985741B2 (en) 2011-07-26
EP1435976B1 (en) 2007-04-18
CA2507926A1 (en) 2003-04-03
KR20040062548A (ko) 2004-07-07
IS6085A (is) 2003-03-27

Similar Documents

Publication Publication Date Title
US8415326B2 (en) Pharmaceutical composition comprising chito-oligomers
Kurita Chitin and chitosan: functional biopolymers from marine crustaceans
EP1270599B1 (en) Salmon-origin chondroitin sulfate
JPH01318002A (ja) コンドロイチン硫酸塩の、デルマタン硫酸塩の、およびヒアルロン酸のスルホアミノ誘導体類、並びにそれらの薬学的性質
JP2019500472A (ja) バイオポリマーを脱アセチル化するための方法
CN102648214B (zh) 纯化透明质酸类的制造方法
JP2001505940A (ja) 抗増殖活性を有する新規な酪酸エステルおよびこれを含む薬剤組成物
BR112013027389B1 (pt) Processo para o preparo de sal sódico de sulfato de condroitina
CN108912237B (zh) N-脱硫酸化糖胺聚糖的衍生物以及作为药物的用途
Ibram Studies on chitosan, chitin and chitooligosaccharides and their biomedical properties
RU2303984C2 (ru) Сверхразветвленный амилопектин для применения в способах хирургического или терапевтического лечения млекопитающих, или в диагностических методах, особенно для применения в качестве объемного плазмозаменителя
RS54854B1 (sr) Hondroitin sulfat nalik onom kod ajkula i proces za njegovo dobijanje
JP4676048B2 (ja) 脱髄性疾患処置剤
JP3955652B2 (ja) 合成アミノ糖類誘導体及びその製造方法
CN117660571A (zh) 增强降血糖活性的贝类糖胺聚糖及其结构改性方法和应用
JP2008519595A (ja) 変性アルギネートおよびその製造方法および用途
JP4462826B2 (ja) 骨疾患治療剤
US20060223781A1 (en) Process for induction of intramolecular migration of sulfates, phosphates, and other oxyanions
CN117510679B (zh) 岩藻糖化硫酸软骨素寡糖的硫酸化衍生物及其应用
US9718947B2 (en) Biotechnological sulphated chondroitin sulphate at position 4 or 6 on the same polysaccharide chain, and process for the preparation thereof
Moussa Synthesis and characterization of chitosan oligomers for biomedical applications
Laroche et al. A novel alginate from the brown seaweed Sargassum turbinaroides (Sargassae)
CN118852492A (zh) 一种岩藻糖化硫酸乙酰肝素及其制备方法与应用
Kren Enzymatic Synthesis of Carbohydrate Ligands for Natural Killer Cells: The Way from Ligand Optimisation Towards Anticancer Glycodrugs
HK40004031A (en) Derivatives of n-desulfated glycosaminoglycans and use as drugs